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TEXAS score 2B and PEDIS score 2 (p < 0.05). No microor-
ganism was associated with amputation, although Staphylococcus
aureus and Gram Negative Bacilli were the ones with greater
amputation rate or severity score (PEDIS, Wagner, TEXAS) at
admission. Medium length of stay was 19 days.
Staphylococcus aureus infection was associated with a pro-
longed length of stay (25 days, p ¼ 0.04). Overall, 74% of gram
positives were sensitive to quinolones and 98% to vancomycin and
90% of gram negatives to cefotaxime and 95% to carbapenems.
Conclusion: TEXAS, PEDIS and Wagner wound classiﬁcation can
predict outcome. MRSA infection was associated with a longer stay.
Empiric therapy with a combination of vancomycin and carbape-
nem will result in coverage of most pathogens involved in DFS.Minimum 10-Year Follow-up of Endovascular Repair for Acute
Traumatic Transection of the Thoracic Aorta
L. Canaud, C. Marty-Ané, V. Ziza, P. Branchereau, P. Alric
CHU de Montpellier, Hospital A de Villeneuveuve, Montpellier, France
Introduction: Thoracic endovascular aortic repair (TEVAR) for
traumatic rupture of the descending thoracic aorta (DTA) appears,
in the short term, to be associated with better outcome, but long
term data is still lacking.
Methods: A review of a prospectively maintained database of
patients who underwent TEVAR for traumatic rupture of the DTA
in our unit with a minimum 10-year follow-up was performed.
Follow-up computed tomography scans were performed at 1
week, at 3 and 6 months, and annually thereafter. Particular
attention was focused on device related issues.
Results: Among the 53 patients who underwent TEVAR for an acute
traumatic rupture of the DTA, 17 of them were at a minimum 10-
year follow-up: mean age 45.8  17 years [18e78], 4 women.
Mean follow up was 11.6 years (range: 10.1e13.1 years). Technical
success was achieved in 100% (Excluder-TAG [7], Talent [9], Zenith
[1]). The distribution of the proximal landing zone was zone 2 in 4
cases, zone 3 in 13 patients. A case of inadvertent coverage of supra-
aortic trunks occurred intra-operatively. An early proximal type I
endoleak was successfully treated by a proximal implantation of a
second stent-graft. No perioperative death was observed and none
of the patients suffered transient or permanent paraplegia, cerebral
complication. At a minimum 10-year follow-up, all the patients are
still alive. Furthermore, follow-up computed tomography scans did
not disclosed any stent-graft migration or collapse, secondary
endoleak or pathologic enlargement of the thoracic aorta.
Conclusion: Our minimum 10-year follow-up study of endovascular
repair for acute traumatic transection of the thoracic aorta
demonstrated that the improved operative mortality of TEVAR
over open, lasts over time without any device or procedure related
issues.
The Inﬂuence of Diabetes Mellitus and Insulin Use on the
Prevalence of AAA Among Patients Referred for Peripheral Artery
Disease
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Introduction: The prevalence of abdominal aortic aneurysm (AAA) is
known to be less among patients with diabetesmellitus (DM).This is
supposed to be a result of a greater arterial wall thickness which
reduces wall stress. The question is whether or not this protectiveeffect can be found among patients with suspected peripheral ar-
tery disease (PAD) who were referred to the vascular surgeon.
Methods: From January 2008 till December 2012, 1956 patients
with suspected PAD were referred to the vascular surgeon. After
exclusion, 1697 patients, 971 men, with an average age of 68
years, were successfully screened with duplex for AAA. Their
relevant patient characteristics were retrospectively gathered (sex,
age, smoking habits, cardiovascular or cerebrovascular history,
hypertension, DM, COPD, dyslipidemia, medication use, Ruth-
erford classiﬁcation and ankle brachial index).
Results: In the screened group, 24.5% has DM and 38% of these
patients use insulin. The prevalence of AAA in the screened group is
7.0% (118 patients). Among the patients with an AAA 19.5% has DM
(23 patients). Four patients with an AAA use insulin. Male sex (OR
3.1 CI 1.95e4.98), higher age (OR 11.53 CI 8.0e34.73) and smoking
(OR 2.9 CI 1.82e4.73) had an independent positive inﬂuence on the
variability and the prevalence of AAA in a multivariate analysis.
Insulin use appears to have an independent and signiﬁcant negative
inﬂuence on the development of AAA (OR 0.3 CI 0.12e0.90).
Conclusion: In the screened group, DM and the use of oral anti-
diabetic agents have no signiﬁcant relationship with the presence
of AAA. However, AAA is signiﬁcantly less present among those
patients who use insulin. The protective effect of DM on the
prevalence of AAA, as seen in the literature, might actually be
dependent on the use of insulin. This effect could be explained by
the fact that patients who use insulin usually have more pro-
gressed disease, which has had more inﬂuence on the vascular
status of the patient. Another possibility is that the lower preva-
lence of AAA in patients with DM, described in the literature, does
not depend on the disease itself, but on the effects of insulin use.Effects of Preconditioning and Post Conditioning Statin
Treatment on Skeletal Muscle in a Murine Model of Critical Limb
Ischemia
A. Lejay, F. Thaveau, C. Delay, A.-L. Charles, J. Zoll, N. Chakfé, B. Geny
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Introduction: Statins are widely used in the prevention of car-
diovascular events, but may cause deleterious effects especially
muscle pain. We wanted to investigate the effect of statins on
mitochondrial skeletal muscle system in our murine model of
critical limb ischemia, depending on whether the treatment is
initiated before or after the onset of critical ischemia.
Methods: 30 Swiss mice, 8 weeks old, divided into 3 groups: 1
control group (n ¼ 10), one preconditioning group treated with
statins 30 days before ischemia until sacriﬁce (n ¼ 10), and one
post-conditioning group treated with statins 6 days after ischemia
until sacriﬁce (n ¼ 10).
Operating protocol: ligature of the right femoral artery (Day 0),
followed by ligature of the right iliac artery (Day 4). The left lower
limb was considered as control. Gastrocnemius muscles were
analyzed at sacriﬁce (Day 30): mitochondrial respiration and pro-
duction of free radicals in the control limb (CL) and ischemic limb (IL)
were examined in the 3 groups.
Results: Analysis of control group muscles showed (IL vs CL):
 An impairment of mitochondrial respiratory chain
characterized by a decrease in the maximum rate of
oxygen consumption (Vmax) by mitochondria (reﬂection
of ATP production): 7.11  1.14 vs. 9.86  mmol02/min/
g 0.86 (p < 0.001).
348 Abstracts An increased production of free radicals: 0.105  0.023
vs. 0.073  0.022 mM/min/mg (p < 0.001).
In the preconditioning group, mitochondrial respiration is
restored in IL (Vmax ¼ 8.85  2.07 vs. 9.08  1.89 mmol02/min/g),
and production of free radicals is reduced (0.084  0.018 vs. 0.082
 0.027 mM/min/mg). There is no difference between IL and CL. In
the post-conditioning group, there is a signiﬁcant alteration, both
in IL and CL, with impaired mitochondrial respiration (Vmax ¼ 5.03
 1.14 vs. 6.78  1.29 mmol02/min/g) and increased production of
free radicals (0.161  0.077 vs. 0.092  0.052 mM/min/mg).
Conclusion: Statins have protective effects on skeletal critical
ischemic muscle in primary prevention. They have deleterious ef-
fects in secondary prevention, by alteration of the mitochondrial
respiratory function and by increased production of free radicals.Nanotopography and Plasma Treatment: Redesigning the Surface
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Introduction: Current vascular graft materials in clinical use, such as
PTFE and Dacron, do not endothelialise and have low unaccept-
able patency rates. The importance of an endothelial cell layer on
the luminal surface of a vascular graft is well-known. The inﬂuence
of topographical features and surface chemistry on cellular adhe-
sion and proliferation is recognised and under investigation. A
nanocomposite polymer has been developed which has shown
promise as a vascular graft material due to its compliant, biocom-
patible and anti-thrombogenic properties. However, despite these
beneﬁts a lack of endothelialisation is still a cause for major concern.
Our aim in this work is to investigate the potential of plasma
treatment and topographical structures on the luminal graft sur-
face to enhance the self-endothelialisation potential of a nano-
composite vascular graft material.
Methods: POSS-PCU is a polycarbonate urea urethane (PCU) with
a nanoparticle, polyhedral oligomeric silsesquioxane (POSS)
incorporated within it and fabricated according to published pro-
tocols. Microgrooves (MG) of pitch 25 mm were fabricated using
photolithography and nanopits, Near-Square (NSQ), were fabri-
cated using electron beam lithography. These were then embossed
onto the POSS-PCU polymer and replication ﬁdelity was conﬁrmed
using atomic force microscopy (AFM) and scanning electron mi-
croscopy (SEM). The samples then underwent oxygen plasma
treatment at different powers at a ﬁxed time (40 W, 60 W, 80 W at
60 seconds). Successful plasma treatment was conﬁrmed by water
contact angle (WCA) measurements.
Human Umbilical Vein Endothelial Cells (HUVECs) were seeded
onto the treated polymer samples and cell proliferation was
measured using Live/Dead Cell staining. Immunostaining of vinculin
and actin was conducted to observe cell morphology and adhesion.
Results: The embossing of the micro- and nanostructures were
replicated with high ﬁdelity, as seen by SEM and AFM. The micro-
grooves have a pitch size of 25mm.NSQwas also veriﬁed to be120nm
pits with centre-centre spacing of 300 nm with 50 nm offset in pit
placement. Oxygen plasma treatment of the different samples, show
that increase in power increased signiﬁcantly the hydrophilicity of the
samples (p < 0.05). These had a direct impact on giving the optimal
surface on which HUVECs preferentially proliferate and adhere, withan average WCA of 68, giving the highest HUVEC growth. HUVEC
proliferation was seen to increase on NSQ surfaces over MG and
planar samples, retaining both morphology and function.
Conclusion: These exciting observations indicate an important role
for nanotopography and plasma treatment in the development of
vascular grafts.Cost-effectiveness Analysis of Open and Endovascular Repair for
Ruptured Abdominal Aortic Aneurysm
A. Aber, M. Ali, E. Choke, M. Bown, R. Sayers
Department of Cardiovascular Sciences, Leicester University, United Kingdom
Introduction: Emergency endovascular repair (EVAR) for ruptured
abdominal aortic aneurysm (rAAA) may have lower operative
mortality rates than open surgical repair. Concerns remain that the
early survival beneﬁt after EVAR for rAAA may be offset by later
interventions. The aim of this study was to analyse the cost-
effectiveness of EVAR compared with standard open repair (OR)
in the treatment of rAAA.
Methods: A model-based costeutility analysis was performed esti-
matingmean costs andquality-adjusted life-years (QALYs) per patient
in the UK National Health Service with a 1-year time horizon. A de-
cision tree model was constructed and populated with probabilities,
outcomes and cost data from IMPROVE, AJAX & NOTTINGHAM trials
and NHS reference cost for rAAA for 30 days mortality. Probabilities,
outcomes and cost data for long-term complications were obtained
frompublisheddata on elective repair of AAA because of lackdata for
rAAA. This method of using the best available data to make reason-
able assumption in economic models is a common method used by
several groups. This is to make the economic model more credible
and to capture the effects of long-term complications on the cost-
effectiveness of EVAR vs. OSR. The results from the model were
assessed using one-way and probabilistic sensitivity analyses.
Results: The cost of EVAR and open repair combined with the cost
of the long term complications over one year were £5533.40 and
£5963.75 respectively. Both treatments costs were well below the
lower margin of the societal willingness to pay in the UK (£20000)
for one gained QALY. The net monetary beneﬁt (NBM) for OSR was
£25448.3e47442.6 compared to EVAR with NBM £18198.5e
36046.1. The NBM is a recommend method to assess cost-
effectiveness by the national institute of health and care excel-
lence (NICE).
Conclusion: Performing OSR on rAAA is a cost effective strategy
with better NBM when compared to EVAR. However both EVAR
and OSR cost less than the societal willingness threshold for the
QALYs gained.Mid-term Survival and Reinterventions After Endovascular
Versus Open Repair in Ruptured Abdominal Aortic Aneurysms
S.C. van Beek, A.C. Vahl, W. Wisselink, J.A. Reekers, D.A. Legemate,
R. Balm
Academic Medical Center, Amsterdam, The Netherlands
Introduction: In elective aortic surgery, the mid-term risk of rein-
terventions is higher after endovascular aneurysm repair (EVAR)
than after open repair (OR). In the present study we aimed to
compare the mid-term reintervention free survival after EVAR and
OR in patients with a ruptured abdominal aortic aneurysm (RAAA).
Methods: An observational cohort study was carried out including
all consecutive surgically treated RAAA patients between 2004 and
